Dynamic quotes: Off
|
Company Description (as filed with the SEC)
Intermolecular has pioneered a proprietary approach to accelerate research and development, innovation and time-to-market for the semiconductor and clean energy industries. Through paid collaborative development programs (CDPs) with our customers, we develop proprietary technology and intellectual property (IP) for our customers focused on advanced materials, processes, integration and device architectures. This technology enables our customers to bring optimized, high-volume manufacturing-ready integrated devices to market faster and with less risk than conventional approaches to research and development (R&D). We provide our customers with proprietary technology through various fee arrangements and grant them rights to associated IP, primarily through royalty-bearing licenses. Through paid CDPs and our own development, we have established a portfolio of greater than 1,000 patents and patent applications. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.02 |
| Quarterly EPS Est: | -0.04 |
| PEG Ratio: | -.12 |
|
Mean Recommendation: View Summary / View All |
2 |
Data is provided by Zacks Investment Research
